C. Pan

Most-cited papers

1. Complex Patterns of Protease Inhibitor Resistance among Antiretroviral Treatment-Experienced HIV-2 Patients from Senegal: Implications for Second-Line Therapy

   D. Raugi, Robert A. Smith, S. Ba, M. Touré +12 more

   2013Antimicrobial Agents and Chemotherapy47 citations Open access

   Semantic Scholar

   Save

2. Three Main Mutational Pathways in HIV-2 Lead to High-Level Raltegravir and Elvitegravir Resistance: Implications for Emerging HIV-2 Treatment Regimens

   Robert A. Smith, D. Raugi, C. Pan, M. Coyne +6 more

   2012PLoS ONE37 citations Open access

   Semantic Scholar

   Save

3. In vitro activity of dolutegravir against wild-type and integrase inhibitor-resistant HIV-2

   Robert A. Smith, D. Raugi, C. Pan, P. Sow +3 more

   2015Retrovirology36 citations Open access

   Semantic Scholar

   Save

4. Successful Isolation of Infectious and High Titer Human Monocyte-Derived HIV-1 from Two Subjects with Discontinued Therapy

   Tong Wang, Younong Xu, Haiying Zhu, Thomas Andrus +10 more

   2013PLoS ONE18 citations Open access

   Semantic Scholar

   Save

5. Long-term experience and outcomes of programmatic antiretroviral therapy for HIV-2 infection in Senegal, West Africa.

   D. Raugi, S. Ba, Ousseynou Cisse, K. Diallo +65 more

   2020Clinical Infectious Diseases13 citations Open access

   Semantic Scholar

   Save